Role of Natural Nuclear Factor Erythroid-2-related Factor 2 (Nrf2) Activators in Oral and Head and Neck Cancer Treatment

Curr Cancer Drug Targets. 2023;23(6):425-427. doi: 10.2174/1568009623666230220121725.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Head and Neck Neoplasms* / drug therapy
  • Humans
  • NF-E2-Related Factor 2* / metabolism
  • Oxidative Stress

Substances

  • NF-E2-Related Factor 2